Disease | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
melanoma
|
0.740 | CausalMutation | CLINVAR | Activating Q209L/P mutations in GNAQ or GNA11 (GNAQ/11) are present in approximately 80% of uveal melanomas. | 22733540 | 2012 | |||||
melanoma
|
0.740 | GeneticVariation | BEFREE | Activating Q209L/P mutations in GNAQ or GNA11 (GNAQ/11) are present in approximately 80% of uveal melanomas. | 22733540 | 2012 | |||||
melanoma
|
0.740 | CausalMutation | CLINVAR | Activating Q209L/P mutations in GNAQ or GNA11 (GNAQ/11) are present in approximately 80% of uveal melanomas. | 22733540 | 2012 | |||||
melanoma
|
0.740 | CausalMutation | CLINVAR | Activating Q209L/P mutations in GNAQ or GNA11 (GNAQ/11) are present in approximately 80% of uveal melanomas. | 22733540 | 2012 | |||||
melanoma
|
0.740 | CausalMutation | CLINVAR | Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. | 19078957 | 2009 | |||||
melanoma
|
0.740 | CausalMutation | CLINVAR | Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. | 19078957 | 2009 | |||||
melanoma
|
0.740 | CausalMutation | CLINVAR | Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. | 19078957 | 2009 | |||||
melanoma
|
0.740 | CausalMutation | CLINVAR | GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. | 2549426 | 1989 | |||||
melanoma
|
0.740 | CausalMutation | CLINVAR | GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. | 2549426 | 1989 | |||||
melanoma
|
0.740 | CausalMutation | CLINVAR | GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. | 2549426 | 1989 | |||||
melanoma
|
0.740 | CausalMutation | CLINVAR | Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype. | 22808163 | 2012 | |||||
melanoma
|
0.740 | CausalMutation | CLINVAR | Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype. | 22808163 | 2012 | |||||
melanoma
|
0.740 | CausalMutation | CLINVAR | Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype. | 22808163 | 2012 | |||||
melanoma
|
0.740 | GeneticVariation | BEFREE | Intriguingly, enforced expression of GNAQ(Q209L) progressively eliminated melanocytes from the interfollicular epidermis in adults, possibly explaining the near absence of GNAQ(Q209) mutations in human epithelial melanomas. | 26113083 | 2015 | |||||
melanoma
|
0.740 | CausalMutation | CLINVAR | Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells. | 1328859 | 1992 | |||||
melanoma
|
0.740 | CausalMutation | CLINVAR | Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells. | 1328859 | 1992 | |||||
melanoma
|
0.740 | CausalMutation | CLINVAR | Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells. | 1328859 | 1992 | |||||
melanoma
|
0.740 | CausalMutation | CLINVAR | Mutations in GNA11 in uveal melanoma. | 21083380 | 2010 | |||||
melanoma
|
0.740 | CausalMutation | CLINVAR | Mutations in GNA11 in uveal melanoma. | 21083380 | 2010 | |||||
melanoma
|
0.740 | CausalMutation | CLINVAR | Mutations in GNA11 in uveal melanoma. | 21083380 | 2010 | |||||
melanoma
|
0.740 | CausalMutation | CLINVAR | Oncogenic mutations in GNAQ occur early in uveal melanoma. | 18719078 | 2008 | |||||
melanoma
|
0.740 | CausalMutation | CLINVAR | Oncogenic mutations in GNAQ occur early in uveal melanoma. | 18719078 | 2008 | |||||
melanoma
|
0.740 | CausalMutation | CLINVAR | Oncogenic mutations in GNAQ occur early in uveal melanoma. | 18719078 | 2008 | |||||
melanoma
|
0.740 | CausalMutation | CLINVAR | Protein kinase C inhibitor AEB071 targets ocular melanoma harboring GNAQ mutations via effects on the PKC/Erk1/2 and PKC/NF-κB pathways. | 22653968 | 2012 | |||||
melanoma
|
0.740 | CausalMutation | CLINVAR | Protein kinase C inhibitor AEB071 targets ocular melanoma harboring GNAQ mutations via effects on the PKC/Erk1/2 and PKC/NF-κB pathways. | 22653968 | 2012 |